Hamid Ahmadieh Selected Research

Intravitreal Injections

6/2022	Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study.
1/2020	INTRAVITREAL INJECTION OF PROPRANOLOL FOR THE TREATMENT OF RETINAL CAPILLARY HEMANGIOMA IN A CASE OF VON HIPPEL-LINDAU.
5/2018	CHANGES IN CENTRAL CHOROIDAL THICKNESS AFTER TREATMENT OF DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB CORRELATION WITH CENTRAL MACULAR THICKNESS AND BEST-CORRECTED VISUAL ACUITY.
4/2018	Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.
1/2017	Intravitreal Injection of Bone Marrow Mesenchymal Stem Cells in Patients with Advanced Retinitis Pigmentosa; a Safety Study.
9/2016	A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.
1/2016	Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy.
4/2014	Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab.
10/2013	Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.
7/2013	Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hamid Ahmadieh Research Topics

Disease

16	Macular Edema 06/2022 - 08/2005
12	Choroidal Neovascularization 01/2021 - 06/2007
10	Retinal Detachment (Retinal Detachments) 01/2019 - 12/2003
10	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 06/2007
8	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 11/2003
8	Proliferative Vitreoretinopathy 01/2021 - 08/2005
6	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2019 - 08/2012
5	Retinal Vein Occlusion 06/2022 - 08/2005
4	Vision Disorders (Hemeralopia) 01/2022 - 11/2007
4	Inflammation (Inflammations) 01/2021 - 01/2014
4	Fibrosis (Cirrhosis) 01/2020 - 01/2015
4	Retinal Perforations 06/2019 - 01/2007
4	Retinal Diseases 04/2018 - 08/2012
4	Hemorrhage 07/2013 - 10/2009
3	Diabetes Mellitus 01/2021 - 10/2009
3	Blindness (Hysterical Blindness) 01/2019 - 08/2012
3	Retinal Degeneration 01/2019 - 04/2014
2	Vascular Diseases (Vascular Disease) 02/2021 - 04/2018
2	Neoplasms (Cancer) 01/2020 - 05/2018
2	Melanoma (Melanoma, Malignant) 05/2018 - 01/2017
2	Glaucoma 11/2017 - 08/2017
2	Endophthalmitis (Ophthalmia) 09/2016 - 04/2014
2	Burns 12/2015 - 07/2015
2	Weight Loss (Weight Reduction) 01/2015 - 01/2012
2	Hyperglycemia 01/2015 - 01/2012
2	Osteoma 01/2014 - 11/2007
2	Vitreous Hemorrhage 01/2013 - 10/2009
2	Foreign Bodies (Foreign Body) 05/2005 - 09/2004
1	Low Vision (Subnormal Vision) 01/2022
1	Stargardt Disease 01/2022
1	Retinal Dystrophies 04/2021
1	Hyperoxia 01/2021
1	Atrophy 01/2021
1	Sandhoff Disease (Sandhoff's Disease) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2021
1	Hypertension (High Blood Pressure) 03/2020
1	Capillary Hemangioma 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019
1	Bietti Crystalline Dystrophy 06/2019
1	Lymphoma (Lymphomas) 05/2018
1	Burkitt Lymphoma (Burkitt's Lymphoma) 05/2018
1	Central Serous Chorioretinopathy 04/2018
1	Retinitis 01/2018
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2018
1	Hyperemia 11/2017
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 11/2017

Drug/Important Bio-Agent (IBA)

27	Bevacizumab (Avastin)FDA Link 06/2022 - 08/2005
19	Retinaldehyde (Retinal)IBA 01/2022 - 12/2003
10	Triamcinolone (Aristocort)FDA Link 10/2014 - 09/2006
9	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 09/2016 - 09/2006
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 12/2008
5	fasudil (AT 877)IBA 06/2022 - 07/2013
4	Silicone OilsIBA 01/2019 - 11/2008
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2009
2	afliberceptIBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2015
2	Connective Tissue Growth FactorIBA 01/2021 - 01/2019
2	Neutralizing AntibodiesIBA 01/2021 - 01/2019
2	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 12/2015
2	GoldIBA 05/2018 - 01/2017
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2015 - 01/2012
2	Streptozocin (Streptozotocin)FDA Link 01/2015 - 01/2012
2	ResveratrolIBA 01/2015 - 01/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2014 - 06/2007
1	Hexosaminidases (Hexosaminidase)IBA 01/2021
1	ORALIT (ORS)IBA 03/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2020
1	Therapeutic UsesIBA 01/2020
1	K-115IBA 01/2020
1	Claudin-5IBA 01/2020
1	Rhodopsin (Visual Purple)IBA 11/2019
1	tau Proteins (tau Protein)IBA 10/2019
1	Amino Acids FDA Link 06/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2018
1	RNA Splicing FactorsIBA 01/2018
1	Leukotriene B4IBA 01/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2018
1	4-O-carboxymethylascochlorinIBA 12/2017
1	Blood Glucose (Blood Sugar)IBA 12/2017
1	Ophthalmic Solutions (Eye Drops)IBA 11/2017
1	Protein Kinase InhibitorsIBA 11/2017

Therapy/Procedure

14	Intravitreal Injections 06/2022 - 08/2005
13	Therapeutics 06/2022 - 06/2007
10	Vitrectomy 06/2017 - 08/2005
9	Lasers (Laser) 01/2018 - 11/2007
8	Injections 01/2022 - 09/2006
4	Light Coagulation 07/2009 - 11/2007
3	Scleral Buckling 09/2016 - 08/2005
2	Transplantation 04/2018 - 10/2014
2	Photochemotherapy (Photodynamic Therapy) 10/2014 - 06/2007
2	Operative Surgical Procedures 10/2010 - 07/2009
2	Laser In Situ Keratomileusis (LASIK) 07/2009 - 11/2003
2	Vitreoretinal Surgery 11/2008 - 05/2005
1	Immunotherapy 10/2019
1	Aftercare (After-Treatment) 05/2018
1	Radiotherapy 05/2018
1	Topical Administration 11/2017